RNAi Screen Identifies AXL Inhibition Combined with Cannabinoid WIN55212-2 as a Potential Strategy for Cancer Treatment

• Autori principali: Feifei Li (Autore), Hang Gong (Autore), Xinfei Jia (Autore), Chang Gao (Autore), Peng Jia (Autore), Xin Zhao (Autore), Wenxia Chen (Autore), Lili Wang (Autore), Nina Xue (Autore)
• Natura: Libro
• Pubblicazione: MDPI AG, 2024-11-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

<b>Background and objective</b>: Cannabinoids are commonly used as adjuvant cancer drugs to overcome numerous adverse side effects for patients. The aim of this study was to identify the target genes that show a synergistic anti-tumor role in combination with the cannabinoid WIN55212-2 i...